BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 15163734)

  • 1. Direct binding of hepatitis C virus core to gC1qR on CD4+ and CD8+ T cells leads to impaired activation of Lck and Akt.
    Yao ZQ; Eisen-Vandervelde A; Waggoner SN; Cale EM; Hahn YS
    J Virol; 2004 Jun; 78(12):6409-19. PubMed ID: 15163734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction between complement receptor gC1qR and hepatitis C virus core protein inhibits T-lymphocyte proliferation.
    Kittlesen DJ; Chianese-Bullock KA; Yao ZQ; Braciale TJ; Hahn YS
    J Clin Invest; 2000 Nov; 106(10):1239-49. PubMed ID: 11086025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C virus core protein inhibits human T lymphocyte responses by a complement-dependent regulatory pathway.
    Yao ZQ; Nguyen DT; Hiotellis AI; Hahn YS
    J Immunol; 2001 Nov; 167(9):5264-72. PubMed ID: 11673541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C virus: immunosuppression by complement regulatory pathway.
    Yao ZQ; Ray S; Eisen-Vandervelde A; Waggoner S; Hahn YS
    Viral Immunol; 2001; 14(4):277-95. PubMed ID: 11792059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HCV core/gC1qR interaction arrests T cell cycle progression through stabilization of the cell cycle inhibitor p27Kip1.
    Yao ZQ; Eisen-Vandervelde A; Ray S; Hahn YS
    Virology; 2003 Sep; 314(1):271-82. PubMed ID: 14517080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. gC1qR expression in chimpanzees with resolved and chronic infection: potential role of HCV core/gC1qR-mediated T cell suppression in the outcome of HCV infection.
    Yao ZQ; Shata MT; Tricoche N; Shan MM; Brotman B; Pfahler W; Hahn YS; Prince AM
    Virology; 2006 Mar; 346(2):324-37. PubMed ID: 16368125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HCV core protein binds to gC1qR to induce A20 expression and inhibit cytokine production through MAPKs and NF-κB signaling pathways.
    Song X; Yao Z; Yang J; Zhang Z; Deng Y; Li M; Ma C; Yang L; Gao X; Li W; Liu J; Wei L
    Oncotarget; 2016 Jun; 7(23):33796-808. PubMed ID: 27183919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of the gC1qR sites for the HIV-1 viral envelope protein gp41 and the HCV core protein: Implications in viral-specific pathogenesis and therapy.
    Pednekar L; Valentino A; Ji Y; Tumma N; Valentino C; Kadoor A; Hosszu KK; Ramadass M; Kew RR; Kishore U; Peerschke EI; Ghebrehiwet B
    Mol Immunol; 2016 Jun; 74():18-26. PubMed ID: 27111569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T cell dysfunction by hepatitis C virus core protein involves PD-1/PDL-1 signaling.
    Yao ZQ; King E; Prayther D; Yin D; Moorman J
    Viral Immunol; 2007; 20(2):276-87. PubMed ID: 17603844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HCV core protein interaction with gC1q receptor inhibits Th1 differentiation of CD4+ T cells via suppression of dendritic cell IL-12 production.
    Waggoner SN; Hall CH; Hahn YS
    J Leukoc Biol; 2007 Dec; 82(6):1407-19. PubMed ID: 17881511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of Lck and Fyn tyrosine kinase activities by transmembrane protein tyrosine phosphatase leukocyte common antigen-related molecule.
    Tsujikawa K; Ichijo T; Moriyama K; Tadotsu N; Sakamoto K; Sakane N; Fukada S; Furukawa T; Saito H; Yamamoto H
    Mol Cancer Res; 2002 Dec; 1(2):155-63. PubMed ID: 12496362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SOCS1 and SOCS3 are targeted by hepatitis C virus core/gC1qR ligation to inhibit T-cell function.
    Yao ZQ; Waggoner SN; Cruise MW; Hall C; Xie X; Oldach DW; Hahn YS
    J Virol; 2005 Dec; 79(24):15417-29. PubMed ID: 16306613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of cytotoxic T lymphocyte-associated molecule-4 by Src kinases.
    Chuang E; Lee KM; Robbins MD; Duerr JM; Alegre ML; Hambor JE; Neveu MJ; Bluestone JA; Thompson CB
    J Immunol; 1999 Feb; 162(3):1270-7. PubMed ID: 9973379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement regulatory protein Crry/p65-mediated signaling in T lymphocytes: role of its cytoplasmic domain and partitioning into lipid rafts.
    Jiménez-Periañez A; Ojeda G; Criado G; Sánchez A; Pini E; Madrenas J; Rojo JM; Portolés P
    J Leukoc Biol; 2005 Dec; 78(6):1386-96. PubMed ID: 16301324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Src tyrosine kinase Lck binds to CD2, CD4-1, and CD4-2 T cell co-receptors in channel catfish, Ictalurus punctatus.
    Taylor EB; Wilson M; Bengten E
    Mol Immunol; 2015 Aug; 66(2):126-38. PubMed ID: 25771179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-talk between programmed death-1 and suppressor of cytokine signaling-1 in inhibition of IL-12 production by monocytes/macrophages in hepatitis C virus infection.
    Zhang Y; Ma CJ; Ni L; Zhang CL; Wu XY; Kumaraguru U; Li CF; Moorman JP; Yao ZQ
    J Immunol; 2011 Mar; 186(5):3093-103. PubMed ID: 21263070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The multiligand-binding protein gC1qR, putative C1q receptor, is a mitochondrial protein.
    Dedio J; Jahnen-Dechent W; Bachmann M; Müller-Esterl W
    J Immunol; 1998 Apr; 160(7):3534-42. PubMed ID: 9531316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The anti-apoptotic effect of Notch-1 requires p56lck-dependent, Akt/PKB-mediated signaling in T cells.
    Sade H; Krishna S; Sarin A
    J Biol Chem; 2004 Jan; 279(4):2937-44. PubMed ID: 14583609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C virus core protein reduces CD8
    Khan ST; Karges W; Cooper CL; Crawley AM
    Immunology; 2018 May; 154(1):156-165. PubMed ID: 29266204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in binding of PI 3-kinase to the src-homology domains 2 and 3 of p56 lck and p59 fyn tyrosine kinases.
    Susa M; Rohner D; Bichsel S
    Biochem Biophys Res Commun; 1996 Mar; 220(3):729-34. PubMed ID: 8607833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.